GO:0042883 L-cysteine transport: Amino Acid Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042883 (L-cysteine transport) describes the directed movement of L-cysteine into, out of, or within a cell by transporters or pores.
• L-cysteine transport is mediated by multiple transporter families, including high-affinity glutamate transporters, LAT1/LAT2, MATE1, and CydDC.
• Transporters can exhibit broad substrate specificity, accepting L-cysteine and its derivatives such as L-cystine or N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine.
• L-cysteine transport is critical for antioxidant defense, protein synthesis, and detoxification, and its dysfunction is linked to neurotoxicity and cancer.
• Experimental models for studying L-cysteine transport include knockout, point-mutation, and overexpression cell lines, as well as CRISPR library screening.
• EDITGENE provides CRISPR services to interrogate L-cysteine transport genes, from KO to knock-in and bioinformatics.
Description
L-cysteine is a semi-essential amino acid that plays a central role in protein synthesis, redox homeostasis, and detoxification. The directed movement of L-cysteine across cellular membranes is essential for these processes and is classified under the Gene Ontology term GO:0042883, L-cysteine transport. This process is mediated by a diverse array of transporter proteins that ensure adequate intracellular cysteine levels while preventing toxicity. Understanding L-cysteine transport is fundamental for researchers studying amino acid metabolism, neurobiology, and cancer biology. The transport of L-cysteine is not merely a passive diffusion event; it involves specific carrier proteins that can be regulated and can exhibit substrate promiscuity. For example, high-affinity glutamate transporters (EAATs) over-expressed in HEK cells have been shown to transport L-[14C]cystine and L-[14C]cysteine, linking cysteine transport to glutamate signaling. Similarly, the human L-type large neutral amino acid transporters LAT1 and LAT2 can transport a neurotoxicant, the methylmercury-L-cysteine complex, by molecular mimicry, highlighting the physiological and toxicological relevance of these transporters. These findings underscore the importance of precise experimental models to dissect the molecular mechanisms of L-cysteine transport.
L-cysteine transport At A Glance
| GO ID | GO:0042883 |
|---|---|
| GO term | L-cysteine transport |
| Ontology | biological_process |
| Synonym | cysteine transport |
| Major function | Mediates the movement of L-cysteine across cellular membranes via transporters or pores |
| Related transporters | EAATs, LAT1, LAT2, MATE1, CydDC, SMVT |
| Substrates | L-cysteine, L-cystine, N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine, methylmercury-L-cysteine complex |
| Physiological relevance | Antioxidant defense, protein synthesis, detoxification, neurotransmission |
What Is GO:0042883?
GO:0042883, L-cysteine transport, is defined as the directed movement of L-cysteine into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This biological process encompasses the translocation of the amino acid L-cysteine across biological membranes, which is essential for its utilization in metabolic pathways and for maintaining cellular homeostasis.
Why Is L-cysteine transport Important in Cell Biology?
L-cysteine transport is vital for maintaining intracellular cysteine levels, which are required for the synthesis of glutathione, a major antioxidant, and for protein synthesis. Dysregulation of L-cysteine transport has been implicated in various pathological conditions, including neurodegeneration, cancer, and heavy metal toxicity. Moreover, transporters that mediate L-cysteine transport can also transport toxic compounds, such as the methylmercury-L-cysteine complex, leading to neurotoxicity. Therefore, understanding the mechanisms and regulation of L-cysteine transport is crucial for developing therapeutic strategies and for interpreting toxicological data.
• L-cysteine transport is essential for glutathione synthesis and cellular redox balance.
• Transporters like LAT1 and LAT2 can mediate the uptake of neurotoxic methylmercury-L-cysteine complexes, linking cysteine transport to neurotoxicity.
• High-affinity glutamate transporters (EAATs) transport L-cysteine and L-cystine, connecting cysteine transport to glutamate homeostasis.
• MATE1 and MRP2 transport L-cysteine derivatives, affecting drug disposition and detoxification.
• The CydDC family of transporters is involved in L-cysteine transport in bacteria, influencing redox homeostasis and antibiotic resistance.
• Dysregulated L-cysteine transport is associated with cancer progression and chemoresistance.
• L-cysteine transport is critical for protein synthesis and post-translational modifications.
• Genetic variations in L-cysteine transporters may affect individual susceptibility to toxins and drugs.
• Studying L-cysteine transport requires robust cell models, such as knockout and overexpression lines.
• CRISPR screening can identify novel regulators of L-cysteine transport.
What Happens During L-cysteine transport?
Substrate Recognition and Binding
In simple terms: The transporter recognizes and binds L-cysteine.
L-cysteine transport begins with the recognition of the substrate by a specific transporter protein. For instance, the human sodium-dependent multivitamin transporter (SMVT) requires a conserved cysteine residue (Cys294) for its function, indicating that substrate binding involves critical amino acid residues. Similarly, the serotonin transporter (SERT) has been used as a model to study external loop topology, which is relevant for understanding how transporters bind substrates. The binding specificity can vary; some transporters like LAT1 and LAT2 accept the methylmercury-L-cysteine complex as a substrate, demonstrating molecular mimicry.
Translocation Across the Membrane
In simple terms: The transporter moves L-cysteine across the cell membrane.
After binding, the transporter undergoes conformational changes to translocate L-cysteine across the lipid bilayer. High-affinity glutamate transporters (EAATs) over-expressed in HEK cells have been shown to transport L-[14C]cysteine, indicating that these transporters can mediate the translocation of L-cysteine. The multidrug resistance associated protein 2 (Mrp2) transports N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine, a metabolite of trichloroethylene, demonstrating that L-cysteine derivatives can also be translocated by ATP-binding cassette transporters. The CydDC family of transporters in bacteria is another example of systems that mediate L-cysteine transport.
Regulation and Modulation
In simple terms: The transport process can be turned up or down.
L-cysteine transport is subject to regulation at multiple levels. For example, the expression and activity of transporters can be modulated by cellular demands. The MATE1 transporter, which has an external COOH terminus and a 13-helix topology, is involved in the transport of organic cations and possibly L-cysteine derivatives. The activity of SMVT is dependent on Cys294, suggesting that redox conditions may regulate transport. Additionally, the transport of L-cysteine by EAATs can be influenced by the presence of other substrates like glutamate.
Physiological Consequences
In simple terms: What happens after L-cysteine gets into the cell.
Once inside the cell, L-cysteine is utilized for protein synthesis, glutathione production, and other metabolic pathways. The transport of L-cysteine by LAT1 and LAT2 can also lead to the intracellular accumulation of neurotoxic methylmercury, resulting in cellular damage. In bacteria, CydDC-mediated L-cysteine transport is important for maintaining redox balance and supporting growth under aerobic conditions. Thus, the physiological consequences of L-cysteine transport are diverse and depend on the specific transporter and cell type.
Key Genes Involved in GO:0042883 L-cysteine transport
The following genes encode transporters and related proteins that mediate or regulate L-cysteine transport.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC1A1 (EAAT3) | High-affinity glutamate transporter that also transports L-cysteine and L-cystine | Studied in HEK cells for cysteine transport |
| SLC1A2 (EAAT2) | Glutamate transporter with cysteine transport activity | Over-expressed in HEK cells to study substrate specificity |
| SLC1A3 (EAAT1) | Glutamate transporter that can transport L-cysteine | Used to investigate transport kinetics |
| SLC7A5 (LAT1) | L-type amino acid transporter that transports methylmercury-L-cysteine complex | Model for neurotoxicant transport |
| SLC7A8 (LAT2) | L-type amino acid transporter that transports methylmercury-L-cysteine complex | Studied for molecular mimicry |
| SLC47A1 (MATE1) | Multidrug and toxin extrusion transporter with 13-helix topology | Potential role in L-cysteine derivative transport |
| ABCC2 (MRP2) | Multidrug resistance associated protein 2 that transports N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine | Model for detoxification |
| SLC5A6 (SMVT) | Sodium-dependent multivitamin transporter requiring Cys294 for function | Studied for structure-function relationships |
| CydDC | Bacterial transporter family involved in L-cysteine transport | Model for redox homeostasis |
| SLC6A4 (SERT) | Serotonin transporter used as a model for transporter topology | Provides insights into external loop topology |
| SLC3A2 (4F2hc) | Heavy chain subunit that associates with LAT1 and LAT2 | Required for LAT1/LAT2 function |
| SLC7A11 (xCT) | Cystine/glutamate antiporter that transports L-cystine | Indirectly affects L-cysteine transport |
| GCLC | Glutamate-cysteine ligase catalytic subunit | Downstream enzyme using transported cysteine |
| GCLM | Glutamate-cysteine ligase modifier subunit | Regulates glutathione synthesis |
| Nrf2 (NFE2L2) | Transcription factor regulating antioxidant response genes | May regulate transporters |
| ATF4 | Transcription factor in integrated stress response | Potential regulator of amino acid transporters |
| mTOR | Kinase regulating cell growth and amino acid sensing | May modulate transporter expression |
How Is L-cysteine transport Regulated?
L-cysteine transport is regulated at transcriptional, post-transcriptional, and post-translational levels. The expression of transporters such as LAT1 and LAT2 can be influenced by amino acid availability and cellular stress. The activity of SMVT is dependent on a critical cysteine residue (Cys294), suggesting redox regulation. In bacteria, the CydDC transporter is regulated in response to oxygen levels and redox state. Additionally, the MATE1 transporter's topology and function may be modulated by external signals. However, specific regulatory pathways such as mTOR or ISR have not been directly linked to L-cysteine transport in the provided citations, so further research is needed.
L-cysteine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC7A5 (LAT1) | Neurotoxicity due to methylmercury transport | Overexpression in HEK cells |
| SLC7A8 (LAT2) | Neurotoxicity due to methylmercury transport | Knockout in neuronal cells |
| ABCC2 (MRP2) | Detoxification of trichloroethylene metabolites | Knockout in hepatocytes |
| SLC5A6 (SMVT) | Metabolic disorders related to biotin uptake | Point mutation at Cys294 |
| CydDC | Bacterial redox homeostasis and antibiotic resistance | Knockout in E. coli |
Neurotoxicity and Neurodegeneration
L-cysteine transport is implicated in neurotoxicity because transporters like LAT1 and LAT2 can mediate the uptake of the methylmercury-L-cysteine complex, a potent neurotoxin. This molecular mimicry allows methylmercury to enter cells via amino acid transporters, leading to neuronal damage. Additionally, high-affinity glutamate transporters that transport L-cysteine may influence glutamate homeostasis, and their dysfunction has been associated with neurodegenerative conditions.
Cancer and Chemoresistance
Altered L-cysteine transport can affect cancer cell survival and drug resistance. For example, the multidrug resistance associated protein 2 (MRP2) transports N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine, a metabolite of trichloroethylene, which may influence detoxification pathways. The CydDC family of transporters, involved in L-cysteine transport, has been linked to redox homeostasis and antibiotic resistance in bacteria, but its role in cancer is not well defined. Further studies are needed to establish direct links between L-cysteine transport and cancer.
Metabolic Disorders
Defects in L-cysteine transport could contribute to metabolic disorders by impairing glutathione synthesis and antioxidant defense. The sodium-dependent multivitamin transporter (SMVT), which requires Cys294 for function, is essential for biotin and pantothenate uptake, and its dysfunction may affect multiple metabolic pathways. However, direct evidence linking L-cysteine transport to specific metabolic diseases is limited in the provided literature.
From L-cysteine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC1A1 mediate L-cysteine transport? | Overexpression in HEK cells |
| What is the role of Cys294 in SMVT function? | Point mutation (C294A) in SMVT |
| Can MRP2 transport L-cysteine derivatives? | Knockout of ABCC2 in mouse hepatocytes |
| Does LAT1 transport methylmercury-L-cysteine? | Knock-in of LAT1 in HEK cells |
| What is the topology of MATE1? | Tagged knock-in with epitope tags |
| Does CydDC affect L-cysteine transport in bacteria? | Knockout of cydDC in E. coli |
How to Study the L-cysteine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive uptake assay | Transport activity | Measure L-[14C]cysteine uptake in cells |
| Site-directed mutagenesis | Functional importance of residues | Identify critical amino acids like Cys294 |
| Chemical labeling | Transporter topology | Determine external loop orientation |
| Heterologous expression | Transport kinetics | Overexpress transporters in HEK cells |
| CRISPR knockout | Gene function | Create isogenic cell lines lacking transporter |
| CRISPR knock-in | Tagged protein localization | Insert epitope tags for imaging |
| RNA-seq | Gene expression | Identify co-regulated transporters |
| Proteomics | Protein interactions | Find binding partners of transporters |
Radioactive Transport Assays
Radioactive transport assays using L-[14C]cysteine are a classic method to measure L-cysteine transport activity. For example, Hayes et al. (2005) used L-[14C]cystine and L-[14C]cysteine to study transport by high-affinity glutamate transporters over-expressed in HEK cells. This method allows quantification of uptake rates and kinetic parameters.
Site-Directed Mutagenesis and Chemical Labeling
Site-directed mutagenesis is used to identify critical residues involved in L-cysteine transport. For instance, Cys294 was shown to be essential for SMVT function using mutagenesis. Chemical labeling with cysteine-reactive reagents can also probe transporter topology, as demonstrated for the serotonin transporter.
Heterologous Expression Systems
Heterologous expression in HEK cells or Xenopus oocytes is widely used to study L-cysteine transport. Over-expression of transporters like EAATs, LAT1, and LAT2 in HEK cells enables detailed characterization of transport properties. These systems are amenable to CRISPR-mediated knockout or knock-in to create isogenic models.
CRISPR Screening and Bioinformatics
CRISPR library screening can identify genes that regulate L-cysteine transport. By using genome-wide knockout libraries, researchers can uncover novel transporters or regulatory factors. Bioinformatics analysis of transcriptomic data can also reveal co-expression networks and potential regulators.
How CRISPR Can Be Used to Study GO:0042883 L-cysteine transport
Knockout
CRISPR knockout of L-cysteine transporter genes, such as SLC1A1 or SLC7A5, can abolish transport activity and reveal their contribution to cellular processes. For example, knocking out ABCC2 (MRP2) in hepatocytes can test its role in transporting N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine. Knockout models are essential for validating transporter specificity.
Point Mutation
CRISPR point mutation can introduce specific amino acid substitutions to study structure-function relationships. For instance, mutating Cys294 in SMVT to alanine can test its requirement for transport activity. Point mutations can also mimic disease-associated variants or alter substrate specificity.
Knock-in
CRISPR knock-in can insert tags or reporter genes into endogenous transporter loci to study localization and dynamics. For example, knocking in an epitope tag into MATE1 can help determine its membrane topology. Knock-in of fluorescent proteins enables live-cell imaging of L-cysteine transport.
Overexpression
CRISPR activation or cDNA overexpression can increase the levels of L-cysteine transporters to study their transport capacity. Overexpressing EAATs in HEK cells has been used to characterize L-cysteine transport. Overexpression models are useful for kinetic studies and for identifying substrates.
How EDITGENE Supports L-cysteine transport Research
Researchers studying L-cysteine transport-related genes often need to determine whether a candidate gene is causally involved in the transport process. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models, enabling functional validation of transporters and regulatory genes.
Contact EDITGENE today to design your custom CRISPR model for L-cysteine transport research.
Frequently Asked Questions About L-cysteine transport
What is GO:0042883?
GO:0042883 is the Gene Ontology term for L-cysteine transport, defined as the directed movement of L-cysteine into, out of, or within a cell by means of a transporter or pore.
What genes are involved in L-cysteine transport?
Genes encoding transporters such as SLC1A1, SLC1A2, SLC1A3, SLC7A5, SLC7A8, SLC47A1, ABCC2, SLC5A6, and CydDC are involved in L-cysteine transport.
How is L-cysteine transported across the cell membrane?
L-cysteine is transported by specific carrier proteins that undergo conformational changes to translocate the amino acid across the lipid bilayer.
What is the role of LAT1 in L-cysteine transport?
LAT1 (SLC7A5) can transport the methylmercury-L-cysteine complex, demonstrating its role in L-cysteine transport and neurotoxicity.
Can L-cysteine transport be studied using CRISPR?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study L-cysteine transport genes.
What diseases are associated with L-cysteine transport?
L-cysteine transport is associated with neurotoxicity, cancer, and metabolic disorders, though direct links require further study.
What methods measure L-cysteine transport activity?
Radioactive uptake assays using L-[14C]cysteine, site-directed mutagenesis, and heterologous expression are common methods.
What is the function of CydDC in L-cysteine transport?
CydDC is a bacterial transporter family involved in L-cysteine transport and redox homeostasis.
How does SMVT transport L-cysteine?
SMVT (SLC5A6) requires a critical cysteine residue (Cys294) for its function, but its direct role in L-cysteine transport is not fully established.
What is the topology of MATE1?
MATE1 has an external COOH terminus and a 13-helix topology, which may influence its transport function.
Conclusion
L-cysteine transport (GO:0042883) is a fundamental biological process mediated by a diverse set of transporters. Its dysregulation is linked to neurotoxicity, cancer, and metabolic disorders. Understanding the molecular mechanisms and regulation of L-cysteine transport requires robust experimental models, and CRISPR-based approaches offer powerful tools for functional dissection. EDITGENE provides comprehensive services to support research in this field.
References
- 1. Ziegler C. 2017. Preface.. Methods Enzymol 594:xi-xii PMID: 28779845
- 2. Hayes D et al.. 2005. Transport of L-[14C]cystine and L-[14C]cysteine by subtypes of high affinity glutamate transporters over-expressed in HEK cells.. Neurochem Int 46(8):585-94 PMID: 15863236
- 3. Tsirulnikov K et al.. 2010. Transport of N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine, a metabolite of trichloroethylene, by mouse multidrug resistance associated protein 2 (Mrp2).. Toxicol Appl Pharmacol 244(2):218-25 PMID: 20060011
- 4. Simmons-Willis TA et al.. 2002. Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.. Biochem J 367(Pt 1):239-46 PMID: 12117417
- 5. Poole RK et al.. 2019. The CydDC family of transporters.. Res Microbiol 170(8):407-416 PMID: 31279084
- 6. Zhang X et al.. 2009. MATE1 has an external COOH terminus, consistent with a 13-helix topology.. Am J Physiol Renal Physiol 297(2):F263-71 PMID: 19515813
- 7. Ghosal A et al.. 2012. Cys(294) is essential for the function of the human sodium-dependent multivitamin transporter.. Biochim Biophys Acta 1818(1):97-102 PMID: 22015582
- 8. Chen JG et al.. 1998. Determination of external loop topology in the serotonin transporter by site-directed chemical labeling.. J Biol Chem 273(20):12675-81 PMID: 9575231
